BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.3834
-0.0256 (-6.26%)
At close: Jun 23, 2026, 4:00 PM EDT
0.3900
+0.0066 (1.72%)
After-hours: Jun 23, 2026, 7:23 PM EDT

BioRestorative Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10101081015
Market Cap Growth
-27.10%5.40%20.82%-19.02%-33.80%-22.64%
Enterprise Value
6.217.49-0.82-2.7-4.32-5.06
Last Close Price
0.381.181.431.742.754.34
PS Ratio
27.3029.0024.6856.1784.42332.14
PB Ratio
3.230.060.060.820.980.71
P/TBV Ratio
0.030.060.070.791.050.25
EV/Sales Ratio
17.3420.82-2.05-18.52-36.05-110.05
EV/EBITDA Ratio
--0.070.180.230.19
EV/EBIT Ratio
--0.070.180.230.19
EV/FCF Ratio
--0.100.410.701.51
Debt / Equity Ratio
-0000.020.02
Net Debt / Equity Ratio
-0.02-0.02-0.06-1.09-1.40-0.94
Net Debt / EBITDA Ratio
0.250.190.910.720.760.78
Net Debt / FCF Ratio
0.300.271.291.652.346.06
Asset Turnover
0.080.040.030.010.010.00
Quick Ratio
2.230.802.914.252.4757.81
Current Ratio
2.350.842.974.372.5359.01
Return on Equity (ROE)
-4.76%-7.88%-7.78%-56.77%-191.91%95.11%
Return on Assets (ROA)
-333.83%-195.40%-95.84%-105.81%-98.20%-196.67%
Return on Invested Capital (ROIC)
-914.63%-532.89%-362.34%-309.97%-464.11%-2059.44%
Return on Capital Employed (ROCE)
-860.63%-359.65%-128.70%-150.23%-117.35%-207.58%
Buyback Yield / Dilution
-38.49%-15.83%-84.05%-16.60%-204.60%-200.92%
Total Shareholder Return
-38.49%-15.83%-84.05%-16.60%-204.60%-200.92%
SEC Filings: 10-K · 10-Q